These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26010076)

  • 1. Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing properties.
    Tawar RG; Colpitts CC; Timm J; Fehm T; Roggendorf M; Meisel H; Meyer N; Habersetzer F; Cosset FL; Berg T; Zeisel MB; Baumert TF
    Hepatology; 2015 Sep; 62(3):726-36. PubMed ID: 26010076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies against extracellular domains of claudin-1 block hepatitis C virus infection in a mouse model.
    Fukasawa M; Nagase S; Shirasago Y; Iida M; Yamashita M; Endo K; Yagi K; Suzuki T; Wakita T; Hanada K; Kuniyasu H; Kondoh M
    J Virol; 2015 May; 89(9):4866-79. PubMed ID: 25673725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations.
    Krieger SE; Zeisel MB; Davis C; Thumann C; Harris HJ; Schnober EK; Mee C; Soulier E; Royer C; Lambotin M; Grunert F; Dao Thi VL; Dreux M; Cosset FL; McKeating JA; Schuster C; Baumert TF
    Hepatology; 2010 Apr; 51(4):1144-57. PubMed ID: 20069648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of single nucleotide polymorphisms in the essential HCV entry factor CD81 on HCV infectivity and neutralization.
    Deest M; Westhaus S; Steinmann E; Manns MP; von Hahn T; Ciesek S
    Antiviral Res; 2014 Jan; 101():37-44. PubMed ID: 24211330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolate-dependent use of claudins for cell entry by hepatitis C virus.
    Haid S; Grethe C; Dill MT; Heim M; Kaderali L; Pietschmann T
    Hepatology; 2014 Jan; 59(1):24-34. PubMed ID: 23775920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.
    Zeisel MB; Koutsoudakis G; Schnober EK; Haberstroh A; Blum HE; Cosset FL; Wakita T; Jaeck D; Doffoel M; Royer C; Soulier E; Schvoerer E; Schuster C; Stoll-Keller F; Bartenschlager R; Pietschmann T; Barth H; Baumert TF
    Hepatology; 2007 Dec; 46(6):1722-31. PubMed ID: 18000990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-α inducible protein 6 impairs EGFR activation by CD81 and inhibits hepatitis C virus infection.
    Meyer K; Kwon YC; Liu S; Hagedorn CH; Ray RB; Ray R
    Sci Rep; 2015 Mar; 5():9012. PubMed ID: 25757571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A view of the E2-CD81 interface at the binding site of a neutralizing antibody against hepatitis C virus.
    Harman C; Zhong L; Ma L; Liu P; Deng L; Zhao Z; Yan H; Struble E; Virata-Theimer ML; Zhang P
    J Virol; 2015 Jan; 89(1):492-501. PubMed ID: 25339761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Piperazinylbenzenesulfonamides as New Inhibitors of Claudin-1 Trafficking and Hepatitis C Virus Entry.
    Riva L; Song OR; Prentoe J; Helle F; L'homme L; Gattolliat CH; Vandeputte A; Fénéant L; Belouzard S; Baumert TF; Asselah T; Bukh J; Brodin P; Cocquerel L; Rouillé Y; Dubuisson J
    J Virol; 2018 May; 92(10):. PubMed ID: 29491159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing host responses in hepatitis C virus infection target viral entry at postbinding steps and membrane fusion.
    Haberstroh A; Schnober EK; Zeisel MB; Carolla P; Barth H; Blum HE; Cosset FL; Koutsoudakis G; Bartenschlager R; Union A; Depla E; Owsianka A; Patel AH; Schuster C; Stoll-Keller F; Doffoël M; Dreux M; Baumert TF
    Gastroenterology; 2008 Nov; 135(5):1719-1728.e1. PubMed ID: 18718838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies against hepatitis C virus-like particles and viral clearance in acute and chronic hepatitis C.
    Baumert TF; Wellnitz S; Aono S; Satoi J; Herion D; Tilman Gerlach J; Pape GR; Lau JY; Hoofnagle JH; Blum HE; Liang TJ
    Hepatology; 2000 Sep; 32(3):610-7. PubMed ID: 10960457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal anti-claudin 1 antibodies prevent hepatitis C virus infection of primary human hepatocytes.
    Fofana I; Krieger SE; Grunert F; Glauben S; Xiao F; Fafi-Kremer S; Soulier E; Royer C; Thumann C; Mee CJ; McKeating JA; Dragic T; Pessaux P; Stoll-Keller F; Schuster C; Thompson J; Baumert TF
    Gastroenterology; 2010 Sep; 139(3):953-64, 964.e1-4. PubMed ID: 20685314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD81 and claudin 1 coreceptor association: role in hepatitis C virus entry.
    Harris HJ; Farquhar MJ; Mee CJ; Davis C; Reynolds GM; Jennings A; Hu K; Yuan F; Deng H; Hubscher SG; Han JH; Balfe P; McKeating JA
    J Virol; 2008 May; 82(10):5007-20. PubMed ID: 18337570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infection of Human Liver Myofibroblasts by Hepatitis C Virus: A Direct Mechanism of Liver Fibrosis in Hepatitis C.
    Aoudjehane L; Bisch G; Scatton O; Granier C; Gaston J; Housset C; Roingeard P; Cosset FL; Perdigao F; Balladur P; Wakita T; Calmus Y; Conti F
    PLoS One; 2015; 10(7):e0134141. PubMed ID: 26214688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD81 and CLDN1 polymorphisms and hepatitis C virus infection susceptibility: a case control study.
    Sun S; Jin G; Kang H
    Gene; 2015 Aug; 567(1):87-91. PubMed ID: 25934191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Virus-neutralizing antibodies to hepatitis C virus.
    Wahid A; Dubuisson J
    J Viral Hepat; 2013 Jun; 20(6):369-76. PubMed ID: 23647953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo.
    Meuleman P; Hesselgesser J; Paulson M; Vanwolleghem T; Desombere I; Reiser H; Leroux-Roels G
    Hepatology; 2008 Dec; 48(6):1761-8. PubMed ID: 19030166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus induces CD81 and claudin-1 endocytosis.
    Farquhar MJ; Hu K; Harris HJ; Davis C; Brimacombe CL; Fletcher SJ; Baumert TF; Rappoport JZ; Balfe P; McKeating JA
    J Virol; 2012 Apr; 86(8):4305-16. PubMed ID: 22318146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intramolecular bond at cluster of differentiation 81 ectodomain is important for hepatitis C virus entry.
    Yang W; Zhang M; Chi X; Liu X; Qin B; Cui S
    FASEB J; 2015 Oct; 29(10):4214-26. PubMed ID: 26116703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles.
    Doerrbecker J; Friesland M; Riebesehl N; Ginkel C; Behrendt P; Brown RJ; Ciesek S; Wedemeyer H; Sarrazin C; Kaderali L; Pietschmann T; Steinmann E
    Hepatology; 2014 Aug; 60(2):508-20. PubMed ID: 24771613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.